Module 9 Records & Reporting Flashcards

Records & Reporting

1
Q

When is financial information submitted to the FDA

A

When a marketing application is submitted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What term describes any ownership interest, stock options, or other financial interest whose value cannot be readily determined through reference to public prices that exceeds 50k during the investigation and for one year after completion

A

Equity Interest

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

T/F
When reporting financial information of a clinical investigator financial information of the spouse and each dependent child of the investigator must also be included.

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A subject of a research study is a passenger in a car involved in a car crash. The subject sustained a broken wrist and mild concussion. The subject was treated and released from the ER. What should the investigator do when they learn of the crash?

A

Report adverse events of both the broken wrist and concussion to the sponsor according to the timetable specified in the protocol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Subject 311 has had elevated WBC counts for the past 2 study visits with no clinical signs or symptoms. “Increased WBC count” is not listed in the investigator’s brochure (IB) as an adverse event. The investigator should ___

A

Report the elevated WBC to the sponsor as an unexpected adverse event.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

During administration of an investigational drug, events occurred such as subject 603 unexpected sx requiring hospitalization, 415 c/o nausea relieved by otc med.

An IND safety report is filed by the sponsor with the FDA for observations associated with subject ___

A

Subject 603 only

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

According to FDA regulation, how long must an IRB retain records

A

3 years after completion of the research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

An environment in which system access is controlled by persons who are responsible for the content of electronic records that are on the system is a ___

A

CLOSED system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

An environment in which system access is not controlled by persons who are responsible for the content of electronic records is a ___

A

OPEN system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the two main objectives of FDA audits and inspecitions

A
  1. ensuring human safety & protection
  2. verifying data accuracy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When a signature is based on cryptography methods of originator authentication it is a ___

A

Digital signature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What’s the difference between a digital signature and electronic signature

A

a digital sig secures a document

an electronic sig verifies the document.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which signature carries a user’s information along with electronic signature

A

Digital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which signature does not contain any authentication attached to them

A

Electronic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

According to ICH E6 GCP, an “audit” is defined as a ___ & ___ examination of trial-related activities and documents

A

systematic & independent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Steps taken for an FDA Inspection at an investigative site (6)

A
  1. investigator notified & date chosen
  2. FDA investigator presents picture ID and notice of inspection (Form FDA 482)
  3. Preliminary meeting
  4. Interviews of key personnel.
  5. inspection of study records
  6. exit interview, issuance of summary of observations (Form FDA 483)
17
Q

What is
Form FDA 482

A

notice of inspection

18
Q

What is
Form FDA 483

A

issuance of summary of observations

19
Q

T/F
The PI is ultimately responsible for record keeping and retention.

20
Q

The overall goal of monitoring, audits, and activities is to

A

ensure the protection of human research subjects and data integrity

21
Q

T/F
Research misconduct is defined as falsification, fabrication or plagiarism in proposing, performing, or reviewing research, or in reporting research results.

22
Q

Any combination of text, graphics, data, audio, pictorial, or other information representation in digital form that is created, modified, maintained, archived, retrieved, or distributed by a computer system is ___

A

an electronic record

23
Q

T/F
If the FDA has disqualified an institution the determination letter will be made available to the public.

24
Q

The FDA defines a trend as a trend of 1.___ items. if it was just a one-time item and it was corrected, the FDA may consider is a 2.___. However, if there is a trend, you receive a written finding called a 3.___

A
  1. 3
  2. observation
  3. 483 report
25
Q

T/F
Clinical trial material (drug/device) can be thrown away at the end of the study by the site without notifying the sponsor.